About Elevation Pharmaceuticals
Elevation Pharmaceuticals is a company based in San Diego (United States) founded in 2007 was acquired by Sunovion in August 2012.. Elevation Pharmaceuticals has raised $77 million across 3 funding rounds from investors including TPG, Canaan and Sunovion. Elevation Pharmaceuticals offers products and services including Drug Pipeline and Clinical Trials. Elevation Pharmaceuticals operates in a competitive market with competitors including MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sunovion Pharmaceuticals Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elevation Pharmaceuticals
Elevation Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Pipeline and Clinical Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for oncology and rare diseases
Conducts trials for innovative health therapies
Funding Insights of Elevation Pharmaceuticals
Elevation Pharmaceuticals has successfully raised a total of $77M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $30.0M
-
First Round
First Round
(21 Jan 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2012 | Amount | Series B - Elevation Pharmaceuticals | Valuation |
investors |
|
| Sep, 2011 | Amount | Series A - Elevation Pharmaceuticals | Valuation | Canaan , Care Capital |
|
| Jan, 2010 | Amount | Series A - Elevation Pharmaceuticals | Valuation | Canaan , Care Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elevation Pharmaceuticals
Elevation Pharmaceuticals has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include TPG, Canaan and Sunovion. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elevation Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elevation Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elevation Pharmaceuticals Comparisons
Competitors of Elevation Pharmaceuticals
Elevation Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of inhalation products for chronic respiratory diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| domain | founded_year | HQ Location |
Inhalation therapies for pulmonology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Elevation Pharmaceuticals
When was Elevation Pharmaceuticals founded?
Elevation Pharmaceuticals was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Elevation Pharmaceuticals located?
Elevation Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Elevation Pharmaceuticals a funded company?
Elevation Pharmaceuticals is a funded company, having raised a total of $77M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jan 21, 2010.
What does Elevation Pharmaceuticals do?
Developer of aerosol drug products for COPD patients. Its lead clinical-stage product EP-101 is an inhalation solution of a long-acting muscarinic antagonist (LAMA) bronchodilator to treat COPD.
Who are the top competitors of Elevation Pharmaceuticals?
Elevation Pharmaceuticals's top competitors include TFF Pharmaceuticals, Theravance Biopharma and MediciNova.
What products or services does Elevation Pharmaceuticals offer?
Elevation Pharmaceuticals offers Drug Pipeline and Clinical Trials.